Codexis Expands and Strengthens its Leadership Team with Two Executive Hires
05 mai 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces the appointment of Stefan Lutz, Ph.D. as...
Codexis to Hold First Quarter 2020 Conference Call on May 7
30 avr. 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., April 30, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report first quarter 2020 financial results after...
Codexis Reports 2019 Fourth Quarter and Full Year Financial Results
27 févr. 2020 16h05 HE
|
Codexis, Inc.
2019 total revenues increased 13% to $68.5 million with product revenue up 15% and R&D revenue up 11% Ten customers contributed more than $1 million each to 2019 revenues Introduces...
Codexis to Present at Two Investment Conferences in March
25 févr. 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
Codexis to Hold 2019 Fourth Quarter and Full Year Conference Call on February 27
20 févr. 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that it will report 2019 fourth quarter and full year financial...
Halal Ingredients Market To Reach USD 66.9 Billion By 2026 | Reports And Data
29 janv. 2020 10h00 HE
|
Reports and Data
New York, Jan. 29, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Halal Ingredients market was valued at USD 46.8 Billion in 2019 and expected to reach...
Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement
10 janv. 2020 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Jan. 10, 2020 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company and developer of novel biotherapeutics, and Nestlé Health Science, a...
Codexis Announces License Agreement with Roche for Enzyme Used in Next Generation Sequencing
23 déc. 2019 07h00 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA...
Codexis Announces the Publication with Merck of an Efficient Enzymatic Cascade Process for Synthesis of Investigational Anti-HIV Agent, Islatravir
05 déc. 2019 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces the publication with Merck, known as MSD outside the United...
Codexis Reports Third Quarter 2019 Financial Results
05 nov. 2019 16h05 HE
|
Codexis, Inc.
Total revenues rose 29% to $21.9 million driven by strength in R&D, product, and CodeEvolver® licensing revenues Eleven customers each contributed at least a quarter million dollars in revenue ...